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Complications related to endoscopic retrograde cholangiopancreatography (ERCP) include pancreatitis, hemorrhage, cholangitis,
and perforation. ERCP-related perforation is uncommon, but mortality rates are high. Diagnosis requires a high clinical suspicion
for early detection to allow optimal management of the perforation and a better prognosis. Treatment depends on the location and
mechanism and increasingly involves nonoperative management. We report a case of successful nonsurgical treatment of a patient
with extensive air involving the peritoneum, retroperitoneum, thorax, mediastinum, and subcutaneous tissues following an ERCP
perforation.
1.Introduction
Endoscopic retrograde cholangiopancreatography (ERCP)
has developed into an essential part of contemporary
gastrointestinal practice since its introduction in 1968 [1]. In
2007, it was estimated that 500,000 ERCPs were performed
annually in the United States [2]. Clinical indications for
ERCP are diverse and include treatment of biliary tract
disorders such as choledocholithiasis, strictures, and bile
leaks; pancreatic disorders such as strictures, cancer, pseu-
docysts, or leaks; as well as ampullary disorders such as
adenomas or sphincter of Oddi dysfunction [3]. Although
ERCP is undoubtedly an invaluable component of inter-
ventional endoscopy, its use is limited by a complication
rate of approximately 4–10% and mortality of 0.4% [2, 4–
7]. Complications of ERCP, in order of frequency, include
pancreatitis (1.3–5.4%), hemorrhage (0.76–3%), cholangi-
tis (0.87–1%), and perforation (0.3–2.1%). The risk of
complications is statistically increased in therapeutic as
compared to diagnostic ERCP at rates of 1.38% and 5.4%,
respectively, and, increasingly, ERCP is performed primarily
for therapy.
Perforation is a potentially serious complication of
ERCP, leading in some cases to peritonitis, sepsis, and even
death. As a result, most perforations after ERCP historically
were treated with surgical repair. However, nonsurgical
management has been shown to be increasingly successful in
the management of most perforations, except for those that
occur distant from the ampulla or bile ducts. We report a
case of perforation as a complication of ERCP which resulted
in large quantity of extraluminal air and was managed
successfully without surgical intervention.
2.CaseReport
A 73-year-old female was hospitalized for sudden onset
of abdominal pain, jaundice, elevated aminotransferases,
and hyperbilirubinemia. She had previous gastrointestinal
surgeries with cholecystectomy and choledochoduodenos-
tomy for congenital biliary obstruction at six months of
age and gastroduodenostomy for bowel obstruction due to
adhesions at ﬁve years. Computed tomography (CT) of the
abdomen with contrast revealed dilated intrahepatic ducts2 Gastroenterology Research and Practice
and a 3.7 × 2.9cm cystic structure adjacent to duodenum.
On percutaneous cholangiography (PTC), a stricture was
seen at the junction of the bile duct remnant and the
cystic structure. A single percutaneous stent was placed
for initial biliary decompression, and then two internal
biliary stents were placed by combined PTC-ERCP. Repeated
biliary brushings and biopsies of the stricture did not detect
malignancy.
TheERCP of notewasperformedtwomonthslater. After
extraction of the previously placed biliary stents, cholan-
giogram showed a persistent biliary anastomotic stricture.
Balloon dilatation was performed and then a total of four
stents, two 10Fr. and two 8.5Fr., were placed across the
anastomosis to maintain patency. The patient remained
stable throughout the procedure, with close monitoring by
anesthesiology, and no complications were noted.
Postoperatively,thepatientdevelopeddyspneaandright-
sided, nonradiating chest pain. Despite normal oxygen satu-
ration on room air, supplemental oxygen via non-rebreather
face mask at 100% provided no relief of her symptoms. She
denied any hematemesis, hemoptysis, cough, dysphagia, or
abdominal pain. She was afebrile and mildly hypertensive,
without tachycardia or tachypnea. Physical exam revealed
subcutaneousemphysemaoftheneck,thorax,abdomen,and
proximal upper and lower extremities. Her heart and lung
sounds were notably decreased. She had mild abdominal
distention, but no peritoneal signs. The remainder of her
examination was normal. Laboratory studies, including arte-
rial blood gas, complete blood count with diﬀerential, basic
metabolicpanel,andcardiacenzymes,wereunrevealing.Her
electrocardiogramshowednormalsinusrhythmwithoutany
acute changes. Portable chest and abdominal X-rays revealed
subcutaneous emphysema, pneumomediastinum, small left
pneumothorax, and retroperitoneal and intraperitoneal free
air (Figures 1 and 2).
CT scan with intravenous and oral contrast of the
thorax, abdomen and pelvis revealed diﬀuse subcutaneous
emphysema (Figures 3–6), bilateral pneumothorax (Figures
3 and 4), pneumomediastinum (Figures 3 and 4), pneu-
moretroperitoneum (Figure 5), and pneumoperitoneum
(Figures5and6).Thepatient’ssolidorganswerenormaland
therewasnoextravasationoforalcontrastintotheabdomen.
The patient was admitted to the intensive care unit where
she started on broad spectrum antibiotics and bowel rest.
She underwent bilateral chest tube placement for decom-
pression of the pneumothroaces. Her dyspnea and chest pain
promptly resolved. Additional diagnostic studies, including
esophagram, nasopharyngoscopy, and laryngoscopy, showed
no gross site of perforation. Serial abdominal and radio-
graphic examinations over the next three days showed
partial resorption of peritoneal air. The patient remained
hemodynamically stable throughout her treatment. Chest
tubes were removed after 3 days, diet advanced without
diﬃculty, and the patient was discharged uneventfully after
one week. On follow-up visits, the patient was doing well
with no residual symptoms. The biliary stents were removed
by a ﬁnal ERCP four months later. Cholangiogram at that
time showed resolution of the anastomotic stricture with
eﬀective spontaneous biliary drainage.
Figure 1: Portable chest X-ray showing subcutaneous emphysema,
pneumomediastinum, and a left pneumothorax (arrow).
Figure 2: Portable abdominal X-ray showing retroperitoneal and
intraperitoneal-free air.
Figure 3: Coronal section of CT thorax showing subcutaneous
emphysema, bilateral pneumothorax, and pneumomediastinum
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Figure 4: Transverse section of CT thorax showing subcutaneous
emphysema, bilateral pneumothorax, and pneumomediastinum
(arrow).
Figure5:TransversesectionofCTabdomenshowingsubcutaneous
emphysema, pneumoperitoneum, and pneumoretroperitoneum
(arrow).
3. Discussion
3.1. Epidemiology. Perforation is an uncommon compli-
cation of ERCP, with an incidence between 0.3% and
2.1% of procedures [2, 4–6, 8–16]. Therapeutic ERCP with
sphincterotomy has a much higher rate of perforation than
diagnostic ERCP (0.8–0.98% and 0.03–0.1%, resp.) [4, 8,
9]. Risk factors for perforation include older age, diﬃculty
and length of the procedure, length of sphincterotomy,
periampullary diverticulum of the duodenum, abnormal
anatomy (Billroth II gastrectomy), dilated bile duct, biliary
duct stricture, sphincter of Oddi dysfunction, and papillary
stenosis [16–18]. In one study, the risk of perforation
increased by 1.26 times for every 10 minutes over the
mean time for procedure completion [12]. A papillotomy
incision beyond the recommended 11 to 1 o’clock position
also carries an increased risk [6]. There is controversy over
whether precut papillotomy increases the risk of perforation
as compared to sphincterotomy alone [17]. In one study,
Figure6:TransversesectionofCTabdomenshowingsubcutaneous
emphysema and pneumoperitoneum.
precut papillotomy was performed in 54% of patients with
subsequent ERCP-related perforations [12].
Although the incidence of ERCP-related perforations is
low, mortality has been reported in up to 20% of patients [2,
4, 9, 14, 16]. In cases where nonsurgical management failed,
mortality increased to 50% [2, 10]. As a result of spillage of
intestinal, biliary, and pancreatic contents into the abdomen,
the most common cause of death is sepsis. A diﬀerence
in outcomes after perforation exists between patients who
were treated without surgery and those who underwent
surgery. This included length of hospital stay, with a mean
of 7 days in those medically managed versus 12–21 days
in those surgically managed [8, 14], and mortality (4%
versus 13% in nonsurgical versus surgical management of
patients, resp.) [9, 14]. Patients who had a delay in diagnosis
and operative therapy (≥12–24 hours after ERCP) had no
diﬀerence in length of hospitalization and complications
compared to those who initially had symptoms signiﬁcant
enough to require surgery, emphasizing the importance of
early diagnosis and management.
3.2. Classiﬁcation and Pathophysiology. There are two main
classiﬁcationsystemsforERCP-relatedperforations.Howard
et al. proposed a 3-group classiﬁcation system based on the
mechanism of ERCP-related perforation [11]. Group I in
the Howard classiﬁcation refers to guidewire perforations,
groupIIperiampullary,andgroupIIIduodenalperforations.
Alternatively, Stapfer et al. classiﬁed perforations into 4 types
based on severity and anatomical location [10]. The two
systems are, for the most part, interchangeable. The Stapfer
classiﬁcation includes the following:
(1) type I: lateral or medial duodenal wall perforations
(Howard group III),
(2) type II: peri-Vaterian injury (Howard group II),
(3) typeIII:bileorpancreaticductinjury(comparableto
Howard group I since majority of these perforations
are caused by guidewire instrumentation),
(4) type IV: presence of retroperitoneal air alone.4 Gastroenterology Research and Practice
Stapfer type I perforations are due to the endoscope
itself, tend to be large, and are usually intraperitoneal.
Manipulation of the ampulla during sphincterotomy or
other therapeutic measures causes type II perforations,
which is the most common type of injury [13]. Guidewire
(type III) perforations typically occur in the distal bile duct
after wire or basket instrumentation near an obstruction.
Type IV injuries generally are not gross perforations. Several
studies have shown that retroperitoneal air seen on CT scan
occurs in up to 29% of asymptomatic patients after an ERCP
[19, 20]. These are caused by the use of compressed air to
maintain patency of the duodenum during the procedure,
regardless of the length of the procedure.
Anyperforationmaypresentwithretroperitonealairthat
tracks to the thorax and subsequently into subcutaneous
tissues, thus causing subcutaneous emphysema. It has been
hypothesized that there are pores in the diaphragm, formed
either congenitally or acquired, that allow air to move
between the abdominal and thoracic cavity [21]. Others
suggest that trauma to the duodenal wall by the endoscope
allows insuﬄated air to enter the mucosa and track along
the perineural and perivascular sheaths to enter the medi-
astinum [22]. In addition, the visceral space of the deep
cervical fascia in the neck surrounds the trachea and esoph-
agus and is contiguous with the diaphragmatic/esophageal
hiatus, hilar vessel interstitium, and major airways of the
thorax [23]. Therefore, this space allows the movement of
air to ﬂow between the retroperitoneum, mediastinum, and
subcutaneous tissues of the neck. This permits subcutaneous
emphysema to form around the upper cervical region, which
then tracks down the endothoracic fascia of the chest wall
to the transversalis fascia of the abdomen to cause diﬀuse
subcutaneous emphysema, as was seen in this case report.
3.3. Diagnosis. A high clinical suspicion is essential for diag-
nosingERCP-relatedperforationstoallowforearlydiagnosis
and subsequent optimal management and better prognosis.
With the use of sedation, older age of patients, and chronic
multiplecomorbidmedicalissues,symptomsmayinitiallybe
masked, making the diagnosis more diﬃcult [14, 24]. Early
diagnosis increases the chance that the patient will initially
be treated nonsurgically, which results in shorter hospital
stays and less complications [8, 18]. Perforation should be
suspected in any patient with abdominal symptoms, chest
pain, shortness of breath, or crepitus following an ERCP.
Since pancreatitis is the most common ERCP complication
and can present with similar symptoms, it must also be
considered on the diﬀerential.
Diagnosis can occur during the ERCP if extravasation
of air or contrast is seen outside the bile ducts and duo-
denum into the retroperitoneal space. In addition, abnor-
mal guidewire position on ﬂuoroscopy may also indicate
perforation [11, 17]. In cases of type I perforations, the
peritoneum or abdominal contents may be visualized during
the procedure since the injury is usually large.
The clinical presentation of patients with perforation in
the postprocedure period is usually nonspeciﬁc. One study
performeda prospective analysisof patients with perforation
after ERCP found that 100% of patients with perforation
had abdominal or ﬂank discomfort, 74% had elevated heart
rate, 64% had mild to moderate abdominal tenderness, 47%
had low-grade fever, 37% had hyperamylasemia (amylase
>150U/L), 32% had mild leukocytosis (WBC count 10,000–
12,000/microliter), 18% had peritoneal signs, and 16%
had subcutaneous emphysema [18]. Usually the degree of
hyperamylasemia is not as elevated as expected in ERCP-
related pancreatitis [6]. In a meta-analysis, a majority of
patients present initially with mild epigastric tenderness that
leads to fever and tachycardia, then peritonitis after several
hours[17].Aretrospectivestudyusedaclinicalscoretocom-
pare patients that underwent operative versus nonoperative
management of the perforation [8]. The clinical index was
comprisedofgivingonepointforeachofthefollowing:fever
(≥38.5◦C), tachycardia (heart rate ≥100bpm), abdominal
guarding on physical examination, and leukocytosis (WBC
count ≥ 10,000). They found that 83% of patients medically
managed had a score of 0 to 1, while 83% of patients that
required surgery had a clinical index score of 3 to 4 (odds
ratio for requiring surgery in patients with a score of 3
to 4 was 40). Although this clinical index has not been
validated prospectively, it emphasizes the important clinical
ﬁndings that help to guide therapy in patients with suspected
perforation. A higher American Society of Anesthesia (ASA)
classiﬁcation also correlated with a higher likelihood of
requiring surgical management in patients with ASA score
≥3[ 9].
Because of its ease of administration, the ﬁrst imaging
study performed is usually an abdominal X-ray. This may
demonstrate retroperitoneal air as streaking opacities in the
right upper quadrant and outlining the kidney margins
and along the psoas muscle [17, 23, 25]. Full expiratory
uprightabdominalX-rayscandistinguishbetweenintraperi-
toneal and retroperitoneal air, as the intraperitoneal air will
decrease and the latter will increase with this maneuver
[23]. Less common and speciﬁc ﬁndings on X-ray include
obliteration of the psoas margin and segmental ileus in or
near the duodenum. Abdominal CT scans usually conﬁrm
the diagnosis of perforation. It is believed that the air in
the retroperitoneal and intraperitoneal space tracks along
inferior vena cava to enter the mediastinal and pleural cav-
ities, resulting in pneumomediastinum and pneumothorax,
respectively. This can be seen on the CT scans of patients
with perforations. Importantly, the amount of air seen on
radiographsdoesnotcorrelatewiththeseverityofthedisease
butusuallyrelatestotheamountofmanipulation performed
after the perforation has occurred [6, 7]. Upper GI (UGI)
series have also been performed on these patients and a
diagnosisofperforationmadewithextravasationofcontrast.
However,thistechniquehasalowersensitivitythanCTscans
to detect microperforations and does not help to rule out
other causes of similar symptoms, such as pancreatitis [18].
Forthisreason,abdominalCTwithoutcontrastisconsidered
the radiographic imaging of choice to detect ERCP-related
perforations in a patient that has abdominal pain or signs of
systemic inﬂammatory response and peritonitis. Even with
all of these radiographic studies, a source of the perforation
may not be detected in up to 10% of cases [26].Gastroenterology Research and Practice 5
Diagnosis of perforation
Type I
(duodenal)
perforation
Immediate
surgical repair
Type II
(periampullary) perforation
1) Hemodynamic instability
2) Peritoneal signs
3) Sepsis
4) Large retroperitoneal or intraperitoneal ﬂuid
collection seen on CT
5) Large contrast extravasation on ERCP/UGI
6) Retained hardware or choledocholithiasis
7) Massive subcutaneous emphysema
Any present
Immediate surgical repair
Failed response in 24 hrs
worsening symptoms
None present
Observe closely with:
1) NPO
2) IV hydration
3) IV antibiotics
4) Repeat imaging (XR/CT) in 24 hrs and serially until
detect improvement
5) Consider biliary/pancreatic secretion diversion with
stent or nasobiliary tube
Type III
(guidewire)
perforation
Usually conservative
management may
consider biliary stent
placement
Type IV
(retroperitoneal
air only)
Observe
Algorithm 1
3.4. Management. T r e a t m e n to fE R C P - r e l a t e dp e r f o r a t i o n s
depends on the type of injury and the patient’s clinical
symptoms. All type I perforations, since they are usually
large, are immediately repaired with general surgery [10,
11, 17, 27]. The type of surgery depends on the extent of
perforation and ranges from oversewing with omental patch
topyloricexclusion,gastrojejunostomy,tubeduodenostomy,
and extensive debridement. Type III perforations usually
close spontaneously and may be conservatively managed or
treated with placement of a biliary stent [11, 27]. Because
type IV perforations demonstrate only retroperitoneal air
and are not true perforations, their course is self limited and
they too are generally managed without surgery. In a recent
case report, a patient with Type IV perforation who had
extensive air extravasation was managed without operative
intervention [28].
The approach to management of type II perforations is
less clear. Most tend to seal spontaneously by 2-3 days, but
10–43% of patients may require surgical repair [10, 15, 29].
Radiographicﬁndingsthatrequiresurgeryincluderetroperi-
toneal or peritoneal ﬂuid on CT, which suggests continued
bile leak from site of perforation, and are associated with
worse prognosis, large contrast extravasation on ERCP or
UGI, and possibly the presence of massive subcutaneous
emphysema. Clinical ﬁndings that require surgery include
peritoneal signs and sepsis, which may be masked since most
of these injuries are retroperitoneal. If none of these ﬁndings
are present, then the patient may be closely monitored
and managed with nothing by mouth, intravenous (IV)
hydration, broad-spectrum IV antibiotics (antifungals may
be added if the clinical course exceeds 3 days), and serial
abdominal exams and radiographic imaging. In some cases,
the patient also may beneﬁt from diversion of bile and
pancreatic secretions from the site of perforation using a
biliary stent or nasobiliary tube, particularly when there are
signs of biliary obstruction or cholangitis [10, 11, 18, 27].
Once the patient demonstrates improvement clinically, the
diet may be initiated and slowly advanced. If a biliary stent is
placed, then it can be removed electively.
Our patient serves as an excellent example of nonsurgical
management of a Stapfer type II or III perforation. The
likely cause of perforation was dilation and stenting at the
anastomosis of common hepatic duct and duodenal divertic-
ulum or choledocele remnant, which can best be understood
as a biliary perforation at the surgical anastomosis. The
initial presentation might readily have led to unnecessary
surgical intervention with massive subcutaneous air, symp-
toms of chest pain and dyspnea, and the radiologic ﬁndings
of marked retroperitoneal, intraperitoneal, mediastinal air
and bilateral pneumothoraces. However, with chest tube
placement, all symptoms resolved and the patient’s clinical
course was entirely uneventful. With close observation and
patience, her hospital stay was shortened and she avoided the
additional risks and morbidity of surgical intervention.6 Gastroenterology Research and Practice
4. Conclusions
ERCP-related perforation is uncommon but has a high mor-
talityrate,makingitafearedcomplication.Becauseitusually
presentswithclinicalﬁndingssimilartothoseofpancreatitis,
a high clinical suspicion is needed to recognize perforation
and initiate therapy promptly to achieve better outcomes.
StapfertypeIperforationsroutinelyrequiresurgeryandtype
IV perforations can be managed with observation alone.
Treatment of Stapfer types II and III must be individualized
based on the clinical and radiographic features of the
patient. In this case of type II or III perforation, massive
subcutaneous emphysema and extensive air throughout the
abdomen and chest might have indicated surgery, but the
outcome was very good with nonoperative management.
As experience grows with the conservative management
of perforation after ERCP, surgery may be required only
for the most compelling indications of ﬂuid extravasation,
peritonitis, or sepsis.
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